Critically ill patients found to be depleted in glutathione, vitamin C, Zinc, and too a lesser extent: vitamin E. The obvious treatment would be to replace those identified deficiencies
young children have a different set of needs than adults. Aesthetically, devices designed for kids are often sleek and colorful, and functionally, they are typically lightweight and adjustable. As any parent knows, young people don't stay the same size for long and since a wheelchair is a major purchase -- don't want a simple growth spurt to render it useless. Wheelchair category offers models that feature seat width and depth adjustability, elevating legrests, and other versatile features. As a weight-bearing activity is critical to proper physical and mental function-which is why children with cerebral palsy, who may sit for stretches in a wheelchair and typically are unable to stand on their own, can benefit greatly from pediatric standers as part of a comprehensive pediatric rehabilitation program. Pediatric standers are offered in passive, active and mobile formats: Passive standers stay in one place and feature a support surface, active standers allow reciprocal movement of the extremities while in a standing position, and mobile standers enable users to self-propel.
Cerebral Palsy Wheelchair:
Cerebral Palsy Wheelchair Description:
The model designed for cerebral palsy child only.
Ultra light weight aluminium alloy frame.
Seat Width 38 cms (15").
Net Weight: 18.5 kgs.
Epoxy powder coated frame.
Detachable arm rest & foot rest provided.
Elevated and swinging foot rest.
Elevated foot rest provided to elevate leg angle.
Height adjustable and detachable head rest.
Hydraulic reclining high back for a comfortable posture.
Hydraulic adjustable seat angle.
Detachable back and seat pad.
Extra cushion upholstery provided to under arm, head & calg Foldable.
Lever and paddle brakes provided.
Safety belt provided.
Maintenance free rear solid wheels.
Cloth look like water proof upholstery.
Anti wheels for better safety and stability.
Extra cushion upholstery provided to under arm, head & leg.
Folding action.
Lever and paddle brakes provide
intraprostatic androgens are not concomitantly increased when serum androgen levels are raised.
The "saturation model" proposes that the prostate is sensitive to very low concentrations of circulating androgens, but that once maximal AR binding is achieved, which occurs at relatively low concentrations of circulating T, further increases in serum T have little impact
men with metastatic prostate cancer given T who had been previously treated with castration had worsening of disease, whereas those without prior castration did not
There is little data to support the withholding of T therapy on the basis of concern for precipitating prostate cancer.
Both intervention data and physiology studies point to minimal effects on the prostate gland when serum T levels are increased to the mid-normal range with T therapy
an individualized care plan to assess the possible risks and benefits of T therapy for each patient is critical to optimizing the use of androgens in male health.
Nice review of the mixed data on Testosterone and Prostate disease. It is clear that Testosterone does not precipitate prostate cancer. The intraprostatic hormone milieu likely is different than that present in the serum. No surprise there. 5alpha reductase decreases prostate volume, PSA, and low-grade prostate cancer, but actually increases aggressive prostate cancer.
Supraphysiologic doping in young men associated with no increase in prostate disease.
PSA no longer to be followed in men < 55. Mortality rate not changed. PSA change of 1.4 ng/ml is appropriate for additional prostate evaluation. Testosterone therapy on average increased 0.5 ng/ml.
Still, no mention of aromatase activity in this article. Why is it that hormone sensitive disease in men is only with regards to androgens and women estrogen.